May 21, 2020 / 8:57 PM / 12 days ago

BRIEF-Navidea Announces Positive Results Of Second Interim Analysis Of Ongoing Phase 2B Study In Rheumatoid Arthritis

May 21 (Reuters) - Navidea Biopharmaceuticals Inc:

* NAVIDEA BIOPHARMACEUTICALS ANNOUNCES POSITIVE RESULTS OF SECOND INTERIM ANALYSIS OF ONGOING PHASE 2B STUDY IN RHEUMATOID ARTHRITIS

* NAVIDEA BIOPHARMACEUTICALS - DATA SUPPORT HYPOTHESIS THAT TC99M TILMANOCEPT IMAGING CAN PROVIDE EARLY INDICATOR OF TREATMENT RESPONSE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below